Market research firm KLAS has found that providers using digital breast tomosynthesis reported a positive return on investment (ROI), despite a lack of reimbursement.
The new report, titled "Breast Tomosynthesis 2013: The Business Case," included interviews with 44 providers, 43 of which said they would buy a tomosynthesis unit again, despite the unpredictable reimbursement environment.
In all, 89% of survey respondents said that digital breast tomosynthesis is helping them achieve a positive return on investment through new patients and referrals, while 39% cited fewer callbacks for false positives and 11% cited patient satisfaction, according to KLAS.
